Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 8;1(1):1-12.
doi: 10.1016/j.mcpdig.2023.01.001. eCollection 2023 Mar.

Artificial Intelligence for Kidney Stone Spectra Analysis: Using Artificial Intelligence Algorithms for Quality Assurance in the Clinical Laboratory

Affiliations

Artificial Intelligence for Kidney Stone Spectra Analysis: Using Artificial Intelligence Algorithms for Quality Assurance in the Clinical Laboratory

Patrick L Day et al. Mayo Clin Proc Digit Health. .

Abstract

Objective: To determine if a set of artificial intelligence (AI) algorithms could be leveraged to interpret Fourier transform infrared spectroscopy (FTIR) spectra and detect potentially erroneous stone composition results reported in the laboratory information system by the clinical laboratory.

Background: Nephrolithiasis (kidney stones) is highly prevalent, causes significant pain, and costs billions of dollars annually to treat and prevent. Currently, FTIR is considered the reference method for clinical kidney stone constituent analysis. This process, however, involves human interpretation of spectra by a qualified technologist and is susceptible to human error.

Methods: This prospective validation study was conducted from October 29, 2020, to October 28, 2021, to test if the addition of AI algorithm overreads to FTIR spectra could improve the detection rate of technologist-misclassified FTIR spectra. The preceding year was used as a control period. Disagreement between the AI overread and technician interpretation was resolved by an independent human interpretation. The rate of verified human misclassifications that resulted in revised reported results was the primary end point.

Results: Spectra of 81,517 kidney stones were reviewed over the course of 1 year. The overall clinical concordance between the technologist and algorithm was 90.0% (73,388/81,517). The report revision rate during the AI implementation period was nearly 8 times higher than that during the control period (relative risk, 7.9; 95% CI, 4.1-15.2).

Conclusion: This study demonstrated that an AI quality assurance check of human spectra interpretation resulted in the identification of a significant increase in erroneously classified spectra by clinical laboratory technologists.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Workflow of Fourier Transformed Infrared (FTIR) spectra classification process
Figure 2
Figure 2
Example of the explainability of the model predictions using SHAP activation profiles. The first row illustrates 2 different reference spectra, pure magnesium ammonium phosphate (MAP, struvite) and ammonium urate (AU). The second row presents the SHAP activation profiles that contributed to the prediction with high confidence (>0.999 for both spectra). SHAP values were generated for the initial validation samples using 600 randomly selected training samples as the background. Fifteen IF features with the largest absolute SHAP values were selected and overlayed on the spectra signal identifying most important individual wavelengths to the prediction. The third row illustrates how the model predictions function on a spectra that combines the MAP and AU in a 60:40 ratio. The activation profiles for this combined element demonstrate how features from the pure spectra are combined into this mixed stone type.

Similar articles

References

    1. Alelign T., Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018;2018 - PMC - PubMed
    1. Romero V., Akpinar H., Assimos D.G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86–e96. - PMC - PubMed
    1. Hyams E.S., Matlaga B.R. Economic impact of urinary stones. Transl Androl Urol. 2014;3(3):278–283. - PMC - PubMed
    1. Strohmaier W.L. Economics of stone disease/treatment. Arab J Urol. 2012;10(3):273–278. - PMC - PubMed
    1. Rule A.D., Lieske J.C., Li X., Melton L.J., 3rd, Krambeck A.E., Bergstralh E.J. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25(12):2878–2886. - PMC - PubMed

LinkOut - more resources